171 related articles for article (PubMed ID: 34549861)
1. Ketamine for treatment-resistant bipolar depression-need for more data!
Singh B; Vande Voort JL; Kung S
Bipolar Disord; 2021 Nov; 23(7):728-729. PubMed ID: 34549861
[No Abstract] [Full Text] [Related]
2. Ketamine as an alternative treatment for treatment-resistant depression.
Dowben JS; Grant JS; Keltner NL
Perspect Psychiatr Care; 2013 Jan; 49(1):2-4. PubMed ID: 23293991
[No Abstract] [Full Text] [Related]
3. Continuation phase intravenous ketamine in adults with treatment-resistant depression.
Vande Voort JL; Morgan RJ; Kung S; Rasmussen KG; Rico J; Palmer BA; Schak KM; Tye SJ; Ritter MJ; Frye MA; Bobo WV
J Affect Disord; 2016 Dec; 206():300-304. PubMed ID: 27656788
[TBL] [Abstract][Full Text] [Related]
4. KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE.
Bobo WV; Vande Voort JL; Croarkin PE; Leung JG; Tye SJ; Frye MA
Depress Anxiety; 2016 Aug; 33(8):698-710. PubMed ID: 27062450
[TBL] [Abstract][Full Text] [Related]
5. Can ketamine be a safe option for treatment-resistant bipolar depression?
Singh B; Vande Voort JL; Frye MA; Kung S
Expert Opin Drug Saf; 2022 Jun; 21(6):717-720. PubMed ID: 35188015
[No Abstract] [Full Text] [Related]
6. Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression.
Ford N; Ludbrook G; Galletly C
Aust N Z J Psychiatry; 2015 Dec; 49(12):1227. PubMed ID: 26058787
[No Abstract] [Full Text] [Related]
7. Progress in treatment-resistant bipolar depression using repeated ketamine infusions.
van den Brink W; van Amsterdam J
Bipolar Disord; 2023 Sep; 25(6):517-518. PubMed ID: 37311591
[No Abstract] [Full Text] [Related]
8. Repeated infusions of ketamine for treatment-resistant bipolar depression in real-world practice.
Zhou Y; Chen X; Ning Y
Bipolar Disord; 2023 Sep; 25(6):515-516. PubMed ID: 37545011
[No Abstract] [Full Text] [Related]
9. Ineffectiveness of Repeated Intravenous Ketamine Infusions in Treatment-Resistant Depression After a Post-Ketamine Relapse: Time for a Rethink?
López-Díaz Á; Fernández-González JL
J Clin Psychopharmacol; 2018 Oct; 38(5):534-536. PubMed ID: 30106877
[No Abstract] [Full Text] [Related]
10. Ketamine administration in depressive disorders: a systematic review and meta-analysis.
Fond G; Loundou A; Rabu C; Macgregor A; Lançon C; Brittner M; Micoulaud-Franchi JA; Richieri R; Courtet P; Abbar M; Roger M; Leboyer M; Boyer L
Psychopharmacology (Berl); 2014 Sep; 231(18):3663-76. PubMed ID: 25038867
[TBL] [Abstract][Full Text] [Related]
11. Ketamine for Treatment-Resistant bipolar depression-A reality check!
Singh B
Bipolar Disord; 2023 May; 25(3):247-248. PubMed ID: 36978284
[No Abstract] [Full Text] [Related]
12. Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder.
Rong C; Park C; Rosenblat JD; Subramaniapillai M; Zuckerman H; Fus D; Lee YL; Pan Z; Brietzke E; Mansur RB; Cha DS; Lui LMW; McIntyre RS
Int J Environ Res Public Health; 2018 Apr; 15(4):. PubMed ID: 29673146
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence.
McIntyre RS; Rodrigues NB; Lipsitz O; Nasri F; Gill H; Lui LM; Subramaniapillai M; Kratiuk K; Teopiz K; Ho R; Lee Y; Mansur RB; Rosenblat JD
J Psychopharmacol; 2021 Feb; 35(2):128-136. PubMed ID: 33040665
[TBL] [Abstract][Full Text] [Related]
14. A preliminary study of adjunctive ketamine for treatment-resistant bipolar depression.
Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Lan XF; Zhang B; Ning YP
J Affect Disord; 2020 Oct; 275():38-43. PubMed ID: 32658821
[TBL] [Abstract][Full Text] [Related]
15. Ketamine's effectiveness in unipolar versus bipolar depression.
Fond G; Boyer L
Psychopharmacology (Berl); 2014 Nov; 231(22):4417-8. PubMed ID: 25315362
[No Abstract] [Full Text] [Related]
16. Safety and Tolerability of Ketamine Use in Treatment-Resistant Bipolar Depression Patients with Regard to Central Nervous System Symptomatology: Literature Review and Analysis.
Włodarczyk A; Cubała WJ
Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32050466
[TBL] [Abstract][Full Text] [Related]
17. The Concurrent Treatment With Intravenous Ketamine and an Irreversible Monoamine Oxidase Inhibitor for Treatment-Resistant Depression Without Hypertensive Crises.
Wang JCC; Swainson J
J Clin Psychopharmacol; 2020; 40(5):515-517. PubMed ID: 32740556
[No Abstract] [Full Text] [Related]
18. [Ketamine infusion therapy in treatment-resistant depression].
Christodoulakis ΤΕ
Psychiatriki; 2021 Dec; 32(Supplement I):64-69. PubMed ID: 34990381
[TBL] [Abstract][Full Text] [Related]
19. Oral racemic ketamine for common clinical contexts in patients with major depressive disorder: An important intervention that treatment guidelines may never include.
Andrade C
Bipolar Disord; 2022 Mar; 24(2):113-114. PubMed ID: 34816542
[No Abstract] [Full Text] [Related]
20. Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression.
Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y
J Psychopharmacol; 2018 Oct; 32(10):1118-1126. PubMed ID: 30260273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
